Logos Global Management LP: holdings and changes
Number 15 of the top 100 funds by copy return. Logos Global Management LP reported 59 US stocks worth $1.7B for the quarter ending 2026-09-30 and changed 16 new, 10 added, 22 trimmed and 25 sold since 2026-06-30.
Copy return, 4 quarters+71.9%
US 500, same time+14.5%
Size$1.7B
Stocks59
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| PRAX Praxis Precision Medicines I | ADD +63% | 7.48% | $124M | 425,000 |
| RVMD Revolution Medicines INC | TRIM -14% | 7.44% | $123M | 600,000 |
| IDYA Ideaya Biosciences INC | TRIM -5% | 6.62% | $110M | 2,850,000 |
| ERAS Erasca INC Com | TRIM -51% | 5.23% | $86M | 5,900,000 |
| ABVX Abivax Sa-Adr | TRIM -15% | 5.21% | $86M | 870,000 |
| CGON Cg Oncology INC | 4.18% | $69M | 975,000 | |
| IRON Disc Medicine INC | ADD +16% | 4.02% | $66M | 1,015,000 |
| BNTX Biontech Se | TRIM -36% | 3.86% | $64M | 650,000 |
| TNGX Tango Therapeutics INC | TRIM -25% | 3.24% | $54M | 2,150,000 |
| MDGL Madrigal Pharmaceuticals INC | BUY | 3.05% | $50M | 100,000 |
| ELVN Enliven Therapeutics INC | ADD +132% | 2.99% | $50M | 1,080,000 |
| DYN Dyne Therapeutics INC | ADD +18% | 2.92% | $48M | 3,000,000 |
| OCUL Ocular Therapeutix INC | ADD +13% | 2.78% | $46M | 6,000,000 |
| DNTH Dianthus Therapeutics INC | TRIM -38% | 2.66% | $44M | 500,000 |
| AVBP Arrivent Biopharma INC | ADD +35% | 2.47% | $41M | 1,350,000 |
| COGT Cogent Biosciences INC | ADD +39% | 2.42% | $40M | 1,250,000 |
| NBIX Neurocrine Biosciences INC | BUY | 2.14% | $36M | 250,000 |
| BLTE Belite Bio INC | TRIM -20% | 2.05% | $34M | 200,000 |
| AXSM Axsome Therapeutics INC | BUY | 1.95% | $32M | 175,000 |
| GPCR Structure Therapeutics INC | ADD +100% | 1.89% | $31M | 1,000,000 |
| OLEMA PHARMACE Olema Pharmaceut | 1.68% | $28M | 3,208,875 | |
| QUIT Achieve Life Sciences INC | TRIM -41% | 1.56% | $26M | 3,200,000 |
| MAZE Maze Therapeutics | TRIM -52% | 1.54% | $25M | 935,000 |
| PBLS Parabilis Medicines, INC. | ADD +43% | 1.46% | $24M | 750,000 |
| APMD Apnimed INC | BUY | 1.46% | $24M | 1,100,000 |
| YARW Yarrow Bioscience INC | BUY | 1.40% | $23M | 1,026,258 |
| TRVI Trevi Therapeutics | TRIM -23% | 1.25% | $21M | 1,445,000 |
| MANE Veradermics INC | TRIM -6% | 1.25% | $21M | 170,000 |
| VERA Vera Therapeutics INC | TRIM -73% | 1.17% | $19M | 600,000 |
| SRPT Sarepta Therapeutics INC | BUY | 1.10% | $18M | 1,000,000 |
| MLTX Moonlake Immunot | TRIM -44% | 1.06% | $18M | 1,500,000 |
| IMCR Immunocore Holdings Limited | TRIM -17% | 0.92% | $15M | 500,000 |
| BHVN Biohaven LTD | BUY | 0.89% | $15M | 1,100,000 |
| CRSP Crispr Therapeutics Ag | TRIM -17% | 0.84% | $14M | 250,000 |
| DFTX Definium Therapeutics INC | ADD +338% | 0.81% | $13M | 350,000 |
| ENTX Entera Bio LTD | BUY | 0.78% | $13M | 4,411,764 |
| DSGN Design Therapeutics INC | TRIM -67% | 0.76% | $13M | 1,000,000 |
| CBIO Crescent Biopharma INC. | TRIM -55% | 0.75% | $12M | 850,000 |
| ETRA Electra Therapeutics INC | BUY | 0.68% | $11M | 1,000,000 |
| NERV Minerva Neurosciences INC | 0.67% | $11M | 3,288,777 | |
| LBRX Lb Pharmaceuticals INC | TRIM -57% | 0.58% | $10M | 250,000 |
| VKTX Viking Therapeutics INC | BUY | 0.39% | $6M | 200,000 |
| EDIT Editas Medicine INC | 0.35% | $6M | 2,222,000 | |
| TNXP Tonix Pharmaceuticals Hldg Co Com New | BUY | 0.32% | $5M | 550,000 |
| OCUPHIRE PHARM Ocuphire Pharma INC | BUY | 0.29% | $5M | 1,000,000 |
| VOGX Vogenx INC | BUY | 0.28% | $5M | 205,000 |
| IMVT Immunovant INC | TRIM -87% | 0.17% | $3M | 85,000 |
| JBIO Jade Biosciences INC | TRIM -82% | 0.17% | $3M | 200,000 |
| OKUR Onkure Therapeutics INC | 0.16% | $3M | 963,855 | |
| TCGX Tcgx Acquisition Corp | BUY | 0.15% | $2M | 200,000 |
| UNCY Unicycive Therapeutics INC | 0.13% | $2M | 473,563 | |
| PTN Palatin Technologies INC | 0.07% | $1M | 129,260 | |
| JATT Jatt II Acquisition Corp | 0.07% | $1M | 100,000 | |
| JTTT Jatt III Acquisition Corp | BUY | 0.07% | $1M | 100,000 |
| RACC Research Alliance Corp III | 0.07% | $1M | 100,000 | |
| SEPN Septerna INC | 0.06% | $900k | 23,548 | |
| AMAN Amanat Acquisition Corp | 0.03% | $500k | 50,000 | |
| LGVN Longeveron INC | BUY | 0.03% | $500k | 192,308 |
| GUTS Fractyl Health INC | TRIM -50% | 0.02% | $300k | 504,965 |
| CLDX Celldex Therapeutics INC | SELL | 0% | was $78M | 0 |
| CMPS Compass Pathways PLC | SELL | 0% | was $32M | 0 |
| MLYS Mineralys Therapeutics INC | SELL | 0% | was $28M | 0 |
| REPL Replimune Group INC | SELL | 0% | was $28M | 0 |
| XENE Xenon Pharmaceuticals INC | SELL | 0% | was $27M | 0 |
| AVTX Avalo Therapeutics INC | SELL | 0% | was $21M | 0 |
| RCUS Arcus Biosciences INC | SELL | 0% | was $20M | 0 |
| SMMT Summit Therapeutics | SELL | 0% | was $20M | 0 |
| SENSEI BIOTHER Sensei Biotherapeutics INC | SELL | 0% | was $18M | 0 |
| DBVT Dbv Technologies S A | SELL | 0% | was $15M | 0 |
| RYTM Rhythm Pharmaceuticals INC | SELL | 0% | was $14M | 0 |
| VOR Vor Biopharma INC | SELL | 0% | was $12M | 0 |
| SRRK Scholar Rock Hldg Corp | SELL | 0% | was $11M | 0 |
| IMMX Immix Biopharma INC | SELL | 0% | was $10M | 0 |
| QTTB Q32 Bio INC. | SELL | 0% | was $10M | 0 |
| ODTX Odyssey Therapeutics, INC. | SELL | 0% | was $10M | 0 |
| ANNX Annexon INC | SELL | 0% | was $9M | 0 |
| RLAY Relay Therapeutics INC | SELL | 0% | was $6M | 0 |
| ACADIA PHARMAC Acadia Pharmacutical INC | SELL | 0% | was $6M | 0 |
| AMLX Amylyx Pharmaceuticals INC Com | SELL | 0% | was $6M | 0 |
| CYBIN INC Cybin INC | SELL | 0% | was $5M | 0 |
| TENX Tenax Therapeutics INC | SELL | 0% | was $4M | 0 |
| QURE Uniqure Nv | SELL | 0% | was $1M | 0 |
| ACRS Aclaris Therapeutics INC | SELL | 0% | was $1M | 0 |
| LGVN Longeveron INC | SELL | 0% | was $900k | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2023-09-30 → 2023-12-31 | +39.6% | +11.2% |
| 2023-12-31 → 2024-03-31 | +6.4% | +10.0% |
| 2024-03-31 → 2024-06-30 | -15.8% | +4.0% |
| 2024-06-30 → 2024-09-30 | +3.9% | +5.4% |
| 2024-09-30 → 2024-12-31 | -8.2% | +2.1% |
| 2024-12-31 → 2025-03-31 | -27.4% | -4.6% |
| 2025-03-31 → 2025-06-30 | +5.3% | +10.5% |
| 2025-06-30 → 2025-09-30 | +28.5% | +7.8% |
| 2025-09-30 → 2025-12-31 | +36.4% | +2.4% |
| 2025-12-31 → 2026-03-31 | +13.1% | -4.6% |
| 2026-03-31 → 2026-06-30 | +26.0% | +14.8% |
| 2026-06-30 → 2026-09-30 | -11.5% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP